Abstract:Background: Angiotensin II (Ang II) can induce cardiac hypertrophy and platelet-derived growth factor(PDGF) also stimulates cardiac hypertrophy. Is AngII responsible for the pathogenesis of cardiac hypertrophy by inducing PDGF receptor expression? Objective: To investigate the effect of mitogen activated protein kinase (MAPK) on the role of cardiac hypertrophy induced by Ang II in cardiac myocytes so as to provide theoretical basis for clinical prevention and cure of cardiac hypertrophy. Design: Controlled experimental study taking cardiac myocytes of cultured neonatal rats as subjects. Setting: Department of pathophysiology in a university. Materials: The experiment was completed in the Department of Pathophysiology, Medical College of Peking University. A total of 80 Wistar rats of either gender, aged 1-3 days, were provided by the Animal Center of Medical College, Peking University. Their hearts were removed for myocyte culture in the Cell Culture Laboratory. Interventions: The cultured neonatal rat cardiac myocytes treated with 10-7mol/L Ang II were Ang II group, and those preincubated with 10-5mol/L PD98059 (an antagonist of MAPK) for 30 minutes and then treated with Ang II were PD98059 group. Cardiac myocytes of normal neonatal rats were as control group. The expression of PDGF-β was detected by western blot at 24 hours. Main outcome measures: Content of PDGF-β receptor in neonatal rat cardiac myocytes. Results: The expression of PDGF-β receptor induced by Ang II at neonatal rat cardiac myocytes markedly increased at 24 hours (432.41 ±54.08) compared with that of control group (197.65±44.10) (q=6.77, P < 0.01). PDGF-β receptor expression of PD98059 group(317.2±21.12) decreased compared with that of Ang II group(q=3.91, P < 0.05). However, the expression did not return to the level of control group, and there was significant difference between PD98059 group and control group(q =3.85, P < 0.05). Conclusion: The results indicate that angiotensin II promotes cardiac hypertrophy through inducing expression of PDGF receptor, in which mitogen activated protein kinase participates in. Maybe it is another important mechanism for Ang II-induced cardiac hypertrophy. The results can provide experimental data for the primary and secondary prevention in heart rehabilitation.

The Mechanism of Peroxisome Proliferators-Activated Receptor α in the Inhibition of Myocardial Extracellular Matrix Remolding Induced by AngiotensinⅡ

Peroxisome proliferators-activated receptor α play a critical role in the inhibition of myocardial fibrosis induced by AngⅡ in vitro

PCSK9 Regulates Myofibroblast Transformation Through the JAK2/STAT3 Pathway to Regulate Fibrosis after Myocardial Infarction.

Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.

Inhibition of Farnesyl Pyrophosphate Synthase Improves Pressure Overload Induced Chronic Cardiac Remodeling

PPARbeta/delta Activation Inhibits Angiotensin II-induced Collagen Type I Expression in Rat Cardiac Fibroblasts.

Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts

Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Through NF-κB/Brg1 and TGF-ß1 Pathways Attenuates Cardiac Remodeling in Pressure-Overloaded Rat Hearts

Cardiac Fibroblast-Specific Knockout of PGC-1α Accelerates AngII-Induced Cardiac Remodeling

Agonists at PPAR‐γ Suppress Angiotensin II‐induced Production of Plasminogen Activator Inhibitor‐1 and Extracellular Matrix in Rat Cardiac Fibroblasts

Inhibition of Histone Demethylase JMJD1C Attenuates Cardiac Hypertrophy and Fibrosis Induced by Angiotensin II

Peroxisome Proliferator-Activated Receptor α Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Angiotensin II-Induced ROS Production

Peroxisome Proliferator-Activated Receptor-γ is Critical to Cardiac Fibrosis.

Expression of Peroxisome Proliferator-Activated Receptor Γ in Myocardial Cells and Microvasculature of Diabetes Myocardial Fibrosis in Rats

Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.

[Effect and Potential Mechanism of Β3-Adrenoceptor Activation on Fibrosis in Cardiac Fibroblast Cell].

Mechanism of cardiac hypertrophy: Effect of mitogen activated protein kinase inhibitor on expression of platelet-derived growth factor receptor induced by angiotensin II in cardiac myocytes

Rosmarinic Acid Attenuates Cardiac Fibrosis Following Long-Term Pressure Overload Via AMPKα/Smad3 Signaling.

Analysis of Molecular Mechanism of Myocardial Remodeling

Cardiomyocyte peroxisome proliferator-activated receptor α is essential for energy metabolism and extracellular matrix homeostasis during pressure overload-induced cardiac remodeling

Microrna-214 Mediates Isoproterenol-Induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts